Why IMU is a multi multi bagger, page-21676

First 21676 Last

Share
Profile

Follow
winning10bagger

1,438 Posts.

59

01/03/24

12:53

Post #: 72693984
Share

Originally posted by Tenacity & Patience: ↑

Shorter's in IMU were given a financial beating on November 6th. Despite indications IMU had reached it's bottom at $0.039c in the weeks leading up to it. There was the same aroma for pending news then, almost identical to now.

To short at present with IMU- especially for a long period, is like playing Russian roulette (for mine). Only this time there's more weighted news once it comes. The Mast study update caused the 250% increase in SP over just two days. Any further additions ( fully expected now that participants have had an additional 3.5 months ) could see a similar reaction with the SP. Couple this incoming likelihood any time over the next few weeks, with LC stating she hopes to make an announcement "Very soon", just two days ago.
Form there take your pick from three ongoing studies and hinted deals being done. This dosn't even considder the FDA fast track approval process in play - Production opportunities for the newly acquired production facilities - NASDQ listings that have the potential to create 20x the investors we see on the ASX.

Given all the above news pending with IMU, who in their right mind would be Shorting IMU. Sure it's a profession for some investors, even employed by the Institution's. There's a reason they have so much money, and its not because they make bad decisions.

As I suggested yesterday- News often follows news with IMU !
When news comes, for mine forget any charts or previous trading history, as the weight of the news we are expecting should be life changing ( over a series of announcements and months). Hopefully for cancer sufferers and all of us capitalists, who have the courage to put their hard earned into their cause.

Be patient- not long now !

-GO IMU!

Not Financial Advice - Opinions Only - DYOR!

Expand

my theory is someone is tipping off the shorters so when they cover be ready

IMU Price at posting: 12.3¢ Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PL3

Patagonia looks to raise $2.15M for South American exploration and development

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

There are more pages in this discussion • 3,710 more messages in this thread...

First 21676 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.1¢		Change 0.001(2.00%)		Mkt cap ! $374.8M

Open	High	Low	Value	Volume
5.0¢	5.2¢	4.9¢	$541.6K	10.76M

Buyers (Bids)

No.	Vol.	Price($)
8	818590	5.0¢

Sellers (Offers)

Price($)	Vol.	No.
5.1¢	249636	1

View Market Depth

No.	Vol.	Price($)
7	618590	0.050
40	5683742	0.049
27	1923707	0.048
12	1004292	0.047
17	975390	0.046

Price($)	Vol.	No.
0.051	249636	1
0.052	3008410	14
0.053	1998507	7
0.054	1087199	6
0.055	1401256	13

Last trade - 16.10pm 09/07/2024 (20 minute delay)

IMU (ASX) Chart

Why IMU is a multi multi bagger, page-21676

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Why IMU is a multi multi bagger, page-21676

Top Stories

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News